The low expression of CLEC3B was associated with poor progression-free survival and overall survival regardless of gender, race, stage or grade of tumor, alcohol consumption, or other status, suggesting that low expression of CLEC3B may be one of the causes of poor prognosis, and this gene could be an prognostic biomarker for HCC patients. The gene discussed is CLEC3B; the disease is neoplasm.